Valérie Lavastre

VHRN Project Coordinator at Institut de recherches cliniques de Montréal (IRCM)
  • Claim this Profile
Contact Information
us****@****om
(386) 825-5501
Location
Greater Montreal Metropolitan Area, CA
Languages
  • francais Native or bilingual proficiency
  • Anglais Professional working proficiency

Topline Score

Topline score feature will be out soon.

Bio

Generated by
Topline AI

You need to have a working account to view this content.
You need to have a working account to view this content.

Experience

    • VHRN Project Coordinator
      • Mar 2019 - Present

    • Scientific Coordinator/ Program Manager
      • Aug 2017 - Mar 2019

      Reseau de recherche en santé de la Vision (RRSV)/ Vision Health Research Network (VHRN) Reseau de recherche en santé de la Vision (RRSV)/ Vision Health Research Network (VHRN)

    • France
    • Research Services
    • 100 - 200 Employee
    • Scientific I
      • Nov 2016 - Jun 2017

      Project Leader for assay development in immunology under GLP compliance (ELISA, competitive inhibition, ADA, dosing formulation, etc). Writing document: validation/study plan, SOPs, ASP. Project Leader for assay development in immunology under GLP compliance (ELISA, competitive inhibition, ADA, dosing formulation, etc). Writing document: validation/study plan, SOPs, ASP.

    • Higher Education
    • 700 & Above Employee
    • Preclinical research agent
      • Oct 2015 - Sep 2016

      Involved in a drug discovery project in collaboration with Roche Pharmaceuticals/Amochem/NeuChem Therapeutics Achieved assay optimization in order to screen drug candidates more efficiently. Developed RTqPCR assay for mechanism and target validation. Optimizing drug candidate in preclinical in vivo experiments (toxicity and efficacy) Involved in a drug discovery project in collaboration with Roche Pharmaceuticals/Amochem/NeuChem Therapeutics Achieved assay optimization in order to screen drug candidates more efficiently. Developed RTqPCR assay for mechanism and target validation. Optimizing drug candidate in preclinical in vivo experiments (toxicity and efficacy)

    • Research
    • 100 - 200 Employee
    • Research Associate
      • Nov 2013 - Aug 2015

      Project Management in Nano-Immunology Strategic thinking for developing new projects (Neutrophils and Eosinophils functions altered in inflammation induced by nanoparticle, experimental Asthma) (troubleshooting, new protocols) Student (graduate and undergraduate) coaching Laboratory management Writings (scientific publications, research report, grants, official etc.) Project Management in Nano-Immunology Strategic thinking for developing new projects (Neutrophils and Eosinophils functions altered in inflammation induced by nanoparticle, experimental Asthma) (troubleshooting, new protocols) Student (graduate and undergraduate) coaching Laboratory management Writings (scientific publications, research report, grants, official etc.)

    • Canada
    • Hospitals and Health Care
    • 500 - 600 Employee
    • PostDoctoral Fellow
      • Sep 2009 - Nov 2013

      Director: Dr Guy A. Rouleau Project Management for a new transgenic mouse model for neuropathy type II (HSAN2). Writings (scientific publications, grants) Director: Dr Guy A. Rouleau Project Management for a new transgenic mouse model for neuropathy type II (HSAN2). Writings (scientific publications, grants)

    • High School Teacher
      • Jan 2007 - Jun 2008

      Physics Science and Technologies Physics Science and Technologies

Education

  • INRS-Institut Armand-Frappier
    Doctorat, Immunologie
    2001 - 2008
  • Université du Québec à Montréal / UQAM
    Programme court de deuxième cyle, Pégagogie de l'enseigement supérieur
    2003 - 2005
  • INRS-Institut Armand-Frappier
    Maîtrise, Sciences expérimentales de la santé
    2000 - 2001
  • Université de Montréal
    Bac es Sc., Microbiologie et virologie
    1995 - 1999
  • Université de Montréal
    Complementary Diploma, Evaluation, Research and Drug Developement
    2011 -

Community

You need to have a working account to view this content. Click here to join now